Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-24 @ 11:29 PM
NCT ID:
NCT05248256
Eligibility Criteria:
Inclusion Criteria:
* Adult patient \> 18 years
* Patients with AJCC (American Joint Committee on Cancer) 8 T1-T4, N1-N3, M0 stage IIIA-IIIC NSCLC (non small cell lung cancer)
* Patients with oligometastatic disease stage IV, M1 disease, in which definitive concurrent chemoradiotherapy to the thorax is planned
* CBC/CMP within these limits
* Absolute lymphocyte count\>500/ml
* Hemoglobin\>8 g/dL
* AST (aspartate aminotransferase)/ALT (alanine transaminase) \<2.5 times of ULN
* Eastern Cooperative Oncology Group (ECOG) 0-2
Exclusion Criteria:
* History of thoracic irradiation
* History of palliative radiation for the current malignancy under consideration
* Patients not being treated with definitive standard of care to the chest
* History of bone marrow disease and or leukemia
* History of prior cytotoxic chemotherapy for a disease other than for the current malignancy
* Polymetastatic disease, defined here as ≥3 or more extrathoracic metastases
* Administration of concurrent immunotherapy during radiation therapy, either as part of another clinical trial or otherwise
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05248256
Study Brief:
Protocol Section:
NCT05248256